SANGUINE CORPORATION & SUBSIDIARY (A Development Stage Company) Consolidated Balance Sheets (Unaudited) (USD $)	Jun. 30, 2012	Dec. 31, 2011
CURRENT ASSETS
Cash	$ 38	$ 1,436
Total Current Assets	38	1,436
PROPERTY AND EQUIPMENT, NET	194	284
TOTAL ASSETS	232	1,720
CURRENT LIABILITIES
Accounts payable	269,804	261,814
Accrued interest	25,930	14,539
Accrued rent	2,700	0
Related party payable	457,241	357,641
Convertible promissory notes payable, net of debt discounts of $35,094 and $64,461, respectively	172,106	121,739
Total Current Liabilities	927,781	755,733
Total Liabilities	927,781	755,733
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS' DEFICIT
Preferred stock, 10,000,000 shares authorized of $0.001 par value, 75,000 and 75,000 shares issued and outstanding, respectively	75	75
Common stock, 200,000,000 shares authorized of $0.001 par value, 7,246,822 shares issued and outstanding, respectively	7,247	7,247
Additional paid in capital	9,823,986	9,817,416
Deficit accumulated during the development stage	(10,758,857)	(10,578,751)
Total Shareholders' Deficit	(927,549)	(754,013)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$ 232	$ 1,720